• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Finance

Scioto Biosciences Receives Series B Investment from Genome & Company

August 13, 2020 Microbiome Times

Scioto Biosciences announced today the closing of a strategic investment of up to $26.5M from Genome & Company and other investors to join in an upcoming tranche. Genome & Company is a leading microbiome company […]

Editor's Choice

Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infection

August 10, 2020 Microbiome Times

Seres Therapeutics, Inc. (Nasdaq: MCRB) today reported positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI). The study showed that […]

Editor's Choice

The integral role of the microbiome in a post-pandemic world

August 10, 2020 Isabelle de Cremoux

At the beginning of 2020, I said to the Seventure team, that this would be the ‘Year of the Microbiome’.I still believe this will be true even in a COVID-19 world when our lives have […]

Editor's Choice

How viruses and bacteria balance each other in the gut microbiome

July 22, 2020 Microbiome Times

The adage “all things in moderation” applies not to just to food and drink, but also to the legions of bacteria inside our guts helping us digest that food and drink. It turns out the […]

Pharma & Human Health

First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes

July 22, 2020 Microbiome Times

ExeGi Pharma LLC, a U.S.-based company focused on developing and commercializing products targeting the human microbiome, including live biotherapeutic products (LBPs), announced today the results of a 70-patient clinical trial evaluating a new biologic drug […]

Pharma & Human Health

Pendulum Therapeutics Announces Clinical Data For Medical Probiotic That Provides The Dietary Management Of Healthy A1C And Blood Glucose Levels

July 22, 2020 Microbiome Times

Pendulum Therapeutics, an evidence-based microbiome company, announced today the publication of their clinical study in the journal BMJ Open Diabetes Research & Care showing the effectiveness of Pendulum’s novel medical probiotic, Pendulum Glucose Control. The […]

Finance

Biose Industrie Raises Eur 30 Million To Strengthen Its Position As The Reference Microbiome Cdmo

July 20, 2020 Microbiome Times

Biose Industrie announced the closing of a €30 million funding round led by Cathay Capital, alongside the company’s management team, banking partners and the Auvergne-Rhône-Alpes region. Thanks to this funding found, Biose Industrie will benefit […]

Pharma & Human Health

Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Bacterial Strains for Treating Skin Conditions

July 13, 2020 Microbiome Times

–Azitra, Inc., a clinical-stage medical dermatology biotech company addressing serious skin conditions by harnessing the microbiome, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,702,558 to the Company […]

Pharma & Human Health

UC San Diego Center for Microbiome Innovation Adds Two Petabytes of Panasas’ HPC Storage for COVID-19 Research

June 30, 2020 Microbiome Times

Researchers at the UC San Diego Center for Microbiome Innovation (CMI), the world’s leading microbiome research organization, have expanded their Panasas® high-performance computing (HPC) storage infrastructure with an additional two petabytes of ActiveStor® data storage […]

Pharma & Human Health

IPA response to 2020 AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders

June 30, 2020 Microbiome Times

The recently published Clinical Practice Guidelines on the role of probiotics in the management of gastrointestinal disorders by the American Gastroenterological Association (AGA) contains some points of discussion, celebration, and contention for the probiotic field. […]

Finance

Novozymes acquires PrecisionBiotics Group to advance its business within human health

June 26, 2020 Microbiome Times

Novozymes announced that it has acquired PrecisionBiotics Group Limited. Based in Cork, Ireland, PrecisionBiotics Group holds a leading position within probiotics for human gut health and is well positioned with several clinically backed products already […]

Posts navigation

« 1 … 47 48 49 … 87 »

Sign Up to Free Newsletter

QIAGEN WEBINAR SERIES – REGISTER HERE

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
    May 1, 2026
  • Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
    April 8, 2026
  • Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
    March 24, 2026
  • Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
    February 11, 2026
  • Immunity as a Lifestyle Priority
    January 30, 2026
sign up

Sign up to the Microbiome Times newsletter